BOPW
BIIB icon

Brandywine Oak Private Wealth’s Biogen BIIB Stock Holding History

Brandywine Oak Private Wealth’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-66
Closed -$19K – 261
2018
Q4 		$19K Buy
+66
New +$21.1K ﹤0.01% 451

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Brandywine Oak Private Wealth's BIIB Position: Q1 2019 in Review

Brandywine Oak Private Wealth sold out of Biogen (BIIB) in Q1 2019, closing a stake of 66 shares — an estimated $19K sold.

Brandywine Oak Private Wealth first reported a position in BIIB in Q4 2018 and held it in 1 quarter. The position peaked at $19K in Q4 2018. 1,084 funds tracked by Wall St. Rank hold BIIB as of Q1 2019.

  • Brandywine Oak Private Wealth reported no remaining Biogen position as of Q1 2019 after selling out during the quarter.
  • Brandywine Oak Private Wealth sold 66 Biogen shares in Q1 2019, an estimated $19K.
  • Brandywine Oak Private Wealth first reported a position in Biogen in Q4 2018 and held it in 1 quarter.
  • Brandywine Oak Private Wealth's Biogen position peaked at $19K in Q4 2018.
  • 1,084 funds tracked by Wall St. Rank held Biogen as of Q1 2019.

Based on Brandywine Oak Private Wealth's 13F filing for Q1 2019, filed 9 May 2019.